Skip to main content
Consensus Study Report

VIEW LARGER COVER

Suggested Citation

National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. https://doi.org/10.17226/24615.

Import this citation to:

Publication Info

260 pages |  8.5 x 11 |  DOI: https://doi.org/10.17226/24615
Chapters skim
Front Matter i-viii
Report 1-18
A. Appendixes Noted in the Report of the Drug Efficacy Study 19-20
APPENDIX A. 1 MEMBERS OF THE EXECUTIVE COMMITTEE OF THE POLICY ADVISORY COMMITIEE DRUG EFFICACY STUDY 21-22
APPENDIX A. 2 CHAIRMEN AND MEMBERS OF PANELS DRUG EFFICACY STUDY 23-38
APPENDIX A. 3 GUIDELINES OF THE DRUG EFFICACY STUDY (August 1966) 39-45
Appendix a. ROSTER OF MEMBERS OF THE POLICY ADVISORY COMMITTEE DRUG EFFICACY STUDY 46-48
Appendix b. FEDERAL REGISTER ANNOUNCEMENT OF 9 JULY, 1966 49-50
Appendix c. DRUG EFFICACY STUDY FORMS 51-54
APPENDIX A. 4 MEMBERS OF THE PROFESSIONAL STAFF DRUG EFFICACY STUDY 55-56
APPENDIX A. 5 REPLIES OF MEMBERS OF PANELS TO LETTER OF 24 JANUAAY 1969 57-102
B. General Statements of Panels on Uses of Selected Categories of Drugs 103-104
APPENDIX B. 1 PANEL ON DRUGS FOR RELIEF OF PAIN 105-108
APPENDIX B. 2 PANEL ON DRUGS USED IN ANESTHESIOLOGY 109-122
APPENDIX B. 3 PANELS ON ANTI-INFECTIVE DRUGS 123-160
APPENDIX B. 4 PANELS ON CARDIOVASCULAR DRUGS 161-184
APPENDIX B. 5 PANEL ON DRUGS USED IN DENTISTRY 185-188
APPENDIX B. 6 PANELS ON DRUGS USED IN DERMATOLOGY 189-194
APPENDIX B. 7 PANELS ON DRUGS USED IN GASTROENTEROLOGY 195-196
APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS 197-212
APPENDIX B. 9 PANEL ON DRUGS USED IN ENDOCRINE DISTURBANCES and PANEL ON DRUGS USED IN METABOLIC DISORDERS 213-218
APPENDIX B. 10 PANEL ON DRUGS USED IN OPHTHALMOLOGY 219-222
APPENDIX B. 11 PANEL ON DRUGS USED IN RHEUMATIC DISEASES 223-232
APPENDIX B. 12 PANEL ON DRUGS USED IN RESPIRATORY DISTURBANCES 233-234
APPENDIX B. 13 PANEL ON DRUGS USED IN SURGERY 235-238
C. White Paper on the Therapeutic Equivalence of Chemically Equivalent Drugs 239-244

What is skim?

The Chapter Skim search tool presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter. You may select key terms to highlight them within pages of each chapter.

Copyright Information

The National Academies Press (NAP) has partnered with Copyright Clearance Center's Marketplace service to offer you a variety of options for reusing NAP content. Through Marketplace, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Marketplace allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Marketplace you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the NAP through Marketplace:

  • Republish text, tables, figures, or images in print
  • Post on a secure Intranet/Extranet website
  • Use in a PowerPoint Presentation
  • Distribute via CD-ROM
  • Photocopy

Click here to obtain permission for the above reuses. If you have questions or comments concerning the Marketplace service, please contact:

Marketplace Support
International +1.978.646.2600
US Toll Free +1.855.239.3415
E-mail: support@copyright.com
marketplace.copyright.com

To request permission to distribute a PDF, please contact our Customer Service Department at customer_service@nap.edu.

loading iconLoading stats for Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration...